Low dose prophylaxis in Tunisian children with haemophilia.

about

Episodic replacement of clotting factor concentrates does not prevent bleeding or musculoskeletal damage - the MUSFIH study.

P2860

Q38749122-F44D5FD7-D0F8-40B5-9930-7AFA7D43124A

P2860

Low dose prophylaxis in Tunisian children with haemophilia.

Item

http://www.wikidata.org/entity/Q39030128

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Low dose prophylaxis in Tunisian children with haemophilia.

@en

Low dose prophylaxis in Tunisian children with haemophilia.

@nl

type

Item

label

Low dose prophylaxis in Tunisian children with haemophilia.

@en

Low dose prophylaxis in Tunisian children with haemophilia.

@nl

prefLabel

Low dose prophylaxis in Tunisian children with haemophilia.

@en

Low dose prophylaxis in Tunisian children with haemophilia.

@nl

P1476

Low dose prophylaxis in Tunisian children with haemophilia

@en

P2093

B Meddeb

http://www.w3.org/2001/XMLSchema#string

H Elmahmoudi

http://www.w3.org/2001/XMLSchema#string

K Zahra

http://www.w3.org/2001/XMLSchema#string

L Jouini

http://www.w3.org/2001/XMLSchema#string

M Achour

http://www.w3.org/2001/XMLSchema#string

W Saied

http://www.w3.org/2001/XMLSchema#string

P2860

Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.

Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s

Validation of a new pediatric joint scoring system from the International Hemophilia Prophylaxis Study Group: validity of the hemophilia joint health score.

Low-dose tertiary prophylactic therapy reduces total number of bleeds and improves the ability to perform activities of daily living in adults with severe haemophilia A: a single-centre experience from Beijing.

Haemophilia prophylaxis in young patients--a long-term follow-up.

Real-life evidence in evaluating effectiveness of treatment in Haemophilia A with a recombinant FVIII concentrate: a non-interventional study in emerging countries.

Pilot testing of the 'Haemo-QoL' quality of life questionnaire for haemophiliac children in six European countries.

Experimental prophylaxis of severe hemophilia with a factor VIII concentrate.

Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized.

Definitions in hemophilia: communication from the SSC of the ISTH.

P304

77-81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HAE.13048

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

E Gouider

P577

2016-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27943510

http://www.w3.org/2001/XMLSchema#string

Low dose prophylaxis in Tunisian children with haemophilia.

about

P2860

P2860

Low dose prophylaxis in Tunisian children with haemophilia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698